Sonnet BioTherapeutics Holdings, Inc. reported on July 18, 2025, that it believes it has met the Nasdaq minimum equity requirement after closing a private placement for $5.5 million and raising an additional $10.5 million from warrant exercises; awaiting formal confirmation from Nasdaq.